ClinicalTrials.Veeva

Menu

Cerebellar TMS and Satiety in Prader-Willi Syndrome

Mass General Brigham logo

Mass General Brigham

Status

Enrolling

Conditions

Prader-Willi Syndrome

Treatments

Device: Repetitive Transcranial Magnetic Stimulation (rTMS)

Study type

Interventional

Funder types

Other

Identifiers

NCT05938543
2023P001354

Details and patient eligibility

About

This study uses a noninvasive technique called transcranial magnetic stimulation (TMS) to study hyperphagia and satiety in Prader-Willi syndrome.

TMS is a noninvasive way of stimulating the brain, using a magnetic field to change activity in the brain. The magnetic field is produced by a coil that is held next to the scalp. In this study, the investigators will be stimulating the brain to learn more about how TMS might improve hyperphagia in Prader-Willi syndrome.

Enrollment

20 estimated patients

Sex

All

Ages

18 to 64 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosis of Prader-Willi syndrome

Exclusion criteria

  • contraindications for TMS or MRI including :
  • history of neurological disorder
  • history of head trauma resulting in loss of consciousness
  • history of seizures or diagnosis of epilepsy or first degree relative family history of epilepsy
  • metal in brain or skull
  • implanted devices such as a pacemaker, medication pump, nerve stimulator or ventriculoperitoneal shunt claustrophobic in MRI

Trial design

Primary purpose

Basic Science

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

20 participants in 1 patient group

Active cerebellum rTMS
Experimental group
Description:
Cerebellar targeted iTBS, once daily, one week
Treatment:
Device: Repetitive Transcranial Magnetic Stimulation (rTMS)

Trial contacts and locations

1

Loading...

Central trial contact

Laura Holsen, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems